IMP321: Phase I/IIa data

An open-label, Swiss Phase I/IIa trial in 16 patients with metastatic melanoma showed that 5

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE